Table 1.
Subject Demographics
| Controls | TBI | p valuec | TBI – good outcome | TBI – bad outcome | p valued | |
|---|---|---|---|---|---|---|
| n | 35 | 84 | 47 | 37 | ||
| Late time point | 32 | |||||
| Ageb | 56 (50, 66) | 56 (40.3, 71.0) | 0.436 | 46 (29, 59) | 70 (56, 76) | 3.19x10−5 |
| Sexa | 16 (45.7%) | 29 (34.5%) | 0.301 | 16 (34.0%) | 13 (35.1%) | 0.999 |
| HLDa | 10 (28.6%) | 31 (36.9%) | 0.407 | 12 (25.5%) | 19 (51.4%) | 0.022 |
| T2DMa | 8 (22.9%) | 33 (39.3%) | 0.095 | 18 (38.3%) | 15 (40.5%) | 0.999 |
| GCS (Total)b | 15 (15, 15) | 15 (15, 15) | 15 (15, 15) | 0.010 | ||
| GCS (Eyes)b | 4 (4, 4) | 4 (4, 4) | 4 (4, 4) | 0.049 | ||
| GCS (Verbal)b | 5 (5, 5) | 5 (5, 5) | 5 (5, 5) | 0.113 | ||
| GCS (Motor)b | 6 (6, 6) | 6 (6, 6) | 6 (6, 6) | 0.999 | ||
| GOSE (discharge)b | 7 (4, 7) | 7 (7, 7) | 4 (4, 5) | 2.20x10−16 | ||
| GOSE (6-months) b | 7 (5, 8) | 7 (6, 8) | 6 (4, 7) | 0.00126 | ||
| mRS (discharge) b | 1 (1, 3) | 1 (1, 1) | 4 (3, 4) | 1.74x10−15 |
Data are presented as an (%) or bmedian (interquartile range).
c
P value for the comparison between control and all TBI subjects.
d
P value for the comparison between TBI subjects with good or bad discharge outcomes. HLD, hyperlipidemia; T2DM, type 2 diabetes mellitus; GCS, Glasgow Coma Scale; GOSE, Glasgow Outcome Scale – Extended; mRS, modified Rankin Scale.